These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 36274396)

  • 1. Smart chitosan-folate hybrid magnetic nanoparticles for targeted delivery of doxorubicin to osteosarcoma cells.
    Amiryaghoubi N; Abdolahinia ED; Nakhlband A; Aslzad S; Fathi M; Barar J; Omidi Y
    Colloids Surf B Biointerfaces; 2022 Dec; 220():112911. PubMed ID: 36274396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: Synthesis, characterization and cytotoxicity studies.
    Rastegari B; Karbalaei-Heidari HR; Zeinali S; Sheardown H
    Colloids Surf B Biointerfaces; 2017 Oct; 158():589-601. PubMed ID: 28750341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid conjugated poly (Amidoamine) dendrimer grafted magnetic chitosan as a smart drug delivery platform for doxorubicin: In-vitro drug release and cytotoxicity studies.
    Soltany P; Miralinaghi M; Pajoum Shariati F
    Int J Biol Macromol; 2024 Feb; 257(Pt 1):127564. PubMed ID: 37865361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
    Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
    Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid-conjugated polyethylene glycol-coated magnetic nanoparticles for doxorubicin delivery in cancer chemotherapy: Preparation, characterization and cytotoxicity on HeLa cell line.
    Erdem M; Yalcin S; Gunduz U
    Hum Exp Toxicol; 2017 Aug; 36(8):833-845. PubMed ID: 27758842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan overlaid Fe
    Karthika V; AlSalhi MS; Devanesan S; Gopinath K; Arumugam A; Govindarajan M
    Sci Rep; 2020 Nov; 10(1):18912. PubMed ID: 33144607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid decorated metal-organic frameworks loaded with doxorubicin for tumor-targeted chemotherapy of osteosarcoma.
    Xu W; Lou Y; Chen W; Kang Y
    Biomed Tech (Berl); 2020 Apr; 65(2):229-236. PubMed ID: 31605575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.
    Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X
    Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterisation of a pH-sensitive magnetic nanocomposite for controlled delivery of doxorubicin.
    Xu SS; Wu J; Jiang W
    J Microencapsul; 2015; 32(6):533-7. PubMed ID: 26289219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
    Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
    Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of surface functionalized hydroxyapatite nanoparticles for enhanced specificity towards tumor cells.
    Verma G; Shetake NG; Pandrekar S; Pandey BN; Hassan PA; Priyadarsini KI
    Eur J Pharm Sci; 2020 Mar; 144():105206. PubMed ID: 31870813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate-conjugated hydrophobicity modified glycol chitosan nanoparticles for targeted delivery of methotrexate in rheumatoid arthritis.
    Wu Z; Xu K; Min J; Chen M; Shen L; Xu J; Jiang Q; Han G; Pan L; Li H
    J Appl Biomater Funct Mater; 2020; 18():2280800020962629. PubMed ID: 33155513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of biocompatible nanocrystalline cellulose against folate receptors as a novel carrier for targeted delivery of doxorubicin.
    Karimian A; Yousefi B; Sadeghi F; Feizi F; Najafzadehvarzi H; Parsian H
    Chem Biol Interact; 2022 Jan; 351():109731. PubMed ID: 34728188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy.
    Rajkumar S; Prabaharan M
    Colloids Surf B Biointerfaces; 2018 Oct; 170():529-537. PubMed ID: 29966906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin.
    Shi Z; Guo R; Li W; Zhang Y; Xue W; Tang Y; Zhang Y
    J Mater Sci Mater Med; 2014 Mar; 25(3):723-31. PubMed ID: 24327111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of SiO2-deposited stearic acid-g-chitosan nanoparticles for doxorubicin delivery.
    Yuan H; Bao X; Du YZ; You J; Hu FQ
    Int J Nanomedicine; 2012; 7():5119-28. PubMed ID: 23055724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of mesoporous magnetic nanocomposites wrapped with chitosan gatekeepers for pH-sensitive controlled release of doxorubicin.
    Wu J; Jiang W; Shen Y; Jiang W; Tian R
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):132-140. PubMed ID: 27770872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid conjugated Fe
    Rana S; Shetake NG; Barick KC; Pandey BN; Salunke HG; Hassan PA
    Dalton Trans; 2016 Nov; 45(43):17401-17408. PubMed ID: 27731450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid-chitosan conjugated nanoparticles for improving tumor-targeted drug delivery.
    Song H; Su C; Cui W; Zhu B; Liu L; Chen Z; Zhao L
    Biomed Res Int; 2013; 2013():723158. PubMed ID: 24282819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate-conjugated chitosan-grafted pH- and thermo-responsive magnetic nanoparticles for targeted therapy of ovarian cancer.
    Fathi M; Barar J; Erfan-Niya H; Omidi Y
    Int J Biol Macromol; 2020 Jul; 154():1175-1184. PubMed ID: 31730949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.